HYBRID PROTEIN BETWEEN CS DERIVED FROM PLASMODIUM AND HBsAg

PROBLEM TO BE SOLVED: To provide a new improved antigen producing not only humoral response but also cellular immune response and to be used in malaria vaccines. SOLUTION: The new improved antigen consists of a new hybrid protein which is composed of part of Plasmodium CS protein and the surface ant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	COHEN JOSEPH, DE WILDE MICHEL
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a new improved antigen producing not only humoral response but also cellular immune response and to be used in malaria vaccines. SOLUTION: The new improved antigen consists of a new hybrid protein which is composed of part of Plasmodium CS protein and the surface antigen of Hepatitis B virus. The use of this new protein for vaccination purposes is also provided. COPYRIGHT: (C)2007,JPO&INPIT